Overview

  • Product name
    Fatty Acid Oxidation Human Flow Cytometry Kit
    See all Fatty Acid Oxidation kits
  • Detection method
    Fluorescent
  • Sample type
    Adherent cells, Suspension cells
  • Assay type
    Quantitative
  • Product overview

    Fatty Acid Oxidation Human Flow Cytometry Kit (ab118183) contains antibodies against key enzymes of the mitochondrial fatty acid oxidation pathway for flow cytometry. The assay combines the power of single cell analysis obtained from flow cytometry with the specificity of antibody-based immunostaining to quantify protein levels in cultured cells. Cells are harvested and fixed/permeabilized in suspension, targets of interest are detected indirectly with highly specific well-characterized monoclonal antibodies that are then labeled with fluorescent antibodies.

  • Notes

    Spin down the contents of the antibody vials upon receipt of the kit. Store all components upright at 4°C. This kit is stable for at least 6 months from receipt.

  • Tested applications
    Suitable for: Functional Studiesmore details

Properties

Applications

Our Abpromise guarantee covers the use of ab118183 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Functional Studies Use at an assay dependent concentration.

Images

  • Antibody specificity demonstrated by immunocytochemistry. Cells were processes with the Flow cytometry protocol as explained above. Panel A shows control fibroblasts and panel B shows deficient fibroblasts. Left panel shows staining with anti-ACADVL ab, center panel with anti-ACADM ab and right panel with anti-HADHA ab.
  • Antibody specificity demonstrated by flow cytometry. Control (blue) and deficient cell lines (red) were targeted with the FAO antibody panel against ACADVL, ACADM and HADHA. Background fluorescence was determined with the supplied negative control (black). After background subtraction, the ACADVL deficient cell line shows a 93% reduction in the level of the ACADVL protein, the ACADM deficient line shows a 57% reduction in the level of the ACADM protein and the LCHAD deficient cell line shows a 50% reduction of in the level of the HADHA protein. The deficient cell lines characterized protein changes are: (1) ACADVL:p.[N122D], (2) ACADM:p[K304E and (3) HADHB:p[R61H];[R247H].

Protocols

References

This product has been referenced in:
  • Cook KL  et al. Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer. Cancer Res 76:5657-5670 (2016). Read more (PubMed: 27698188) »

See 1 Publication for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab118183.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up